BridgeMD
New treatment option for Quality of Life
Official title Effect of Patient-Controlled Transcutaneous Electrical Acupoint Stimulation on Quality of Life in Chronic Cancer Pain
ClinicalTrials.gov ID: NCT07308951
What this study is testing
- What it's testing
- This study aims to objectively evaluate the effect of Patient-Controlled Transcutaneous Electrical Acupoint Stimulation (PC-TEAS) on improving the quality of life in patients with chronic cancer pain, thereby providing evidence-based medical support for its efficacy and offering practical basis for patients to achieve home-based auxiliary treatment based on their own needs. Furthermore, by observing and comparing changes in indicators such as pain-related scores, analgesic consumption, emotional scores, spontaneous bowel movements, and adverse events, this research will comprehensively assess the advantages of PC-TEAS in the management of chronic cancer pain and explore other potential benefits of this intervention for patients.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Age between 18 and 80 years, regardless of gender;
- Diagnosis of primary or metastatic malignant tumor confirmed by histopathology and/or cytology, consistent with the American Cancer Society criteria...
- Presence of cancer-related pain, defined as an average Numeric Rating Scale (NRS) score ≥ 2 over the preceding week or current regular use of opioid...
- Life expectancy ≥ 3 months;
- Eastern Cooperative Oncology Group Performance Status (ECOG-PS) score ≤ 2, stable vital signs, clear consciousness, intact pain perception...
You likely can't join if
- Pain not attributable to cancer;
- Severe cardiopulmonary dysfunction or respiratory depression;
- Implantation of cardiac pacemaker or metallic implants at stimulation sites;
- Local skin lesions or conditions unsuitable for TEAS at the acupoint sites;
- Severe psychiatric disorders or significant cognitive impairment;
- Concurrent participation in other clinical trials that may interfere with the outcome evaluation of this study;
See the full eligibility criteria
- Age between 18 and 80 years, regardless of gender;
- Diagnosis of primary or metastatic malignant tumor confirmed by histopathology and/or cytology, consistent with the American Cancer Society criteria for malignancy;
- Presence of cancer-related pain, defined as an average Numeric Rating Scale (NRS) score ≥ 2 over the preceding week or current regular use of opioid analgesics;
- Life expectancy ≥ 3 months;
- Eastern Cooperative Oncology Group Performance Status (ECOG-PS) score ≤ 2, stable vital signs, clear consciousness, intact pain perception, unimpaired communication, ability to cooperate with study procedures and...
- Provision of signed informed consent by the patient or their legal guardian after comprehensive explanation of the study;
- Pain not attributable to cancer;
- Severe cardiopulmonary dysfunction or respiratory depression;
- Implantation of cardiac pacemaker or metallic implants at stimulation sites;
- Local skin lesions or conditions unsuitable for TEAS at the acupoint sites;
- Severe psychiatric disorders or significant cognitive impairment;
- Concurrent participation in other clinical trials that may interfere with the outcome evaluation of this study;
- Previous history of transcutaneous electrical acupoint stimulation (TEAS) or transcutaneous electrical nerve stimulation (TENS);
The study team makes the final eligibility decision.
Where it's taking place
- Zhejiang, Hangzhou, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Zhejiang, Hangzhou, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.